These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Kanazawa N; Tashiro K; Miyachi Y Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. Kanazawa N J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204 [TBL] [Abstract][Full Text] [Related]
4. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799 [TBL] [Abstract][Full Text] [Related]
5. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. Meyer-Wentrup F; Cambi A; Joosten B; Looman MW; de Vries IJ; Figdor CG; Adema GJ J Leukoc Biol; 2009 Mar; 85(3):518-25. PubMed ID: 19028959 [TBL] [Abstract][Full Text] [Related]
6. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000 [TBL] [Abstract][Full Text] [Related]
7. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365 [TBL] [Abstract][Full Text] [Related]
8. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. Merlo A; Calcaterra C; Mènard S; Balsari A J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660 [TBL] [Abstract][Full Text] [Related]
9. Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development. Bayyurt B; Tincer G; Almacioglu K; Alpdundar E; Gursel M; Gursel I J Control Release; 2017 Feb; 247():134-144. PubMed ID: 28069554 [TBL] [Abstract][Full Text] [Related]
10. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells. He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929 [TBL] [Abstract][Full Text] [Related]
12. The C-type lectin receptor DCIR is crucial for the development of experimental cerebral malaria. Maglinao M; Klopfleisch R; Seeberger PH; Lepenies B J Immunol; 2013 Sep; 191(5):2551-9. PubMed ID: 23918990 [TBL] [Abstract][Full Text] [Related]
13. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines. Assaf A; Esteves H; Curnow SJ; Browning MJ Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862 [TBL] [Abstract][Full Text] [Related]
14. Stimulatory type A CpG-DNA induces a Th2-like response in human endothelial cells. Fitzner N; Zahner L; Habich C; Kolb-Bachofen V Int Immunopharmacol; 2011 Nov; 11(11):1789-95. PubMed ID: 21820085 [TBL] [Abstract][Full Text] [Related]
20. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages. Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]